Playback speed
10 seconds
ASCO® 2023 Insights: "Final Survival Data From a Randomized Phase 2 Trial Comparing High-Dose With Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited Stage SCLC"
72 views
June 9, 2023
Login to view comments.
Click here to Login